Hemodynamic Effects of Methylene Blue in Pediatric Cardiac Critical Care Patients: A Descriptive Study of Causal Inference and Cluster Analysis Using High-Fidelity Data. (2026)

Peer-Reviewed Study · Loomba RS, Akbasli IT, Flores S, Farias J, Savorgnan F, Sourour W · March 24, 2026

Loomba RS et al., 2026-03-24: Descriptive single-centre paediatric cardiac ICU study suggesting methylene blue raises blood pressure and oxygen-delivery adequacy in vasoplegia, with response varying by catecholamine and vasopressin dose.

Data from this descriptive study suggest that methylene blue may improve arterial blood pressure, and adequacy of oxygen delivery in critically ill pediatric patients with vasoplegia.

Loomba RS et al., 2026-03-24: Descriptive single-centre paediatric cardiac ICU study suggesting methylene blue raises blood pressure and oxygen-delivery adequacy in vasoplegia, with response varying by catecholamine and vasopressin dose. C5 (paediatric, uncontrolled). Study type: single-centre retrospective mechanistic/physiologic analysis using high-fidelity data (Sickbay); Ann and Robert H. Lurie Children's Hospital of Chicago, USA. N not stated in the abstract text captured. Findings: improvement in vasoactive score, MAP and cerebral/renal NIRS in a subset; response greatest with higher catecholamine and lower vasopressin doses; calcium augmented and vasopressin blunted response. Authors declare no competing interests. Comparator: pre-dose baseline. Pediatr Cardiol 2026 (volume/pages not yet assigned). Study type: uncontrolled series.